课题基金 / 基金详情

ROSWELL PARK CANCER INSTITUTE CENTER SUPPORT GRANT

ROSWELL PARK CANCER INSTITUTE CENTER SUPPORT GRANT
罗斯威尔公园癌症研究所中心支持补助金
批准号:
2414072
负责人:
YOUCEF M RUSTUM
金额:
$196.57万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-12-01 至 2000-04-30

项目摘要

项目成果

YOUCEF M RUSTUM的其他基金

相关文献

中文摘要
翻译
这是癌症中心支持的竞争性更新申请 Roswell Park Cancer Institute(RPCI)国家癌症研究所指定的 综合癌症中心,1985 - 2000年赠款期。下 研究所所长兼首席执行官托马斯B的领导。Tomasi,医学博士,博士, 这项赠款已进入不间断供资的第20个年头。来 在过去的二十年里,CCSG为 RPCI的研究计划。目前的CCSG申请反映了 RPCI研究计划的重大演变和进展, 包括6个成熟程序,2个开发程序和12个共享程序 资源,其中7项是新的或大幅扩大的资源 从研究所核心补助金与格雷斯合并结转 癌症药物中心核心补助金。 自上次CCSG更新以来,RPCI发生了许多变化 研究计划,包括招聘新的高级教师,科学 和临床科室进行了重组,主要资金投入 以及纽约州承诺设计和建造一个新的研究 实验室、动物饲养场、护理塔、流动诊所和诊断和 处理设施,除了对现有的 研究设施。CCSG在规划中发挥着核心作用, 罗斯韦尔的基础和临床的评估,支持和管理 研究项目。随着CCSG的更新,结合 纽约州承诺支持罗斯威尔公园的癌症使命 罗斯威尔公园及其高度敬业的研究人员将准备 进入下一个世纪,成为全国领先的癌症中心之一。
英文摘要
This is a competitive renewal application for the Cancer Center Support Grant of Roswell Park Cancer Institute (RPCI). an NCI-designated Comprehensive Cancer Center, for the grant period 1985 - 2000. Under the leadership of Institute President and CEO, Thomas B. Tomasi, M.D., Ph.D, this grant is entering its 20th year of uninterrupted funding. Over the past two decades, the CCSG has provided indispensable support to the research programs of RPCI. The present CCSG application reflects the significant evolution and progress of RPCIs research programs with the inclusion of 6 mature programs, 2 developing programs and 12 shared resources, seven of which are new or significantly expanded resources carried over from the merger of the Institute Core Grant with the Grace Cancer Drug Center Core Grant. Since the last CCSG renewal, there have been numerous changes in the RPCI research programs including recruitment of new senior faculty, scientific and clinical departments have been reorganized, major capital investments and the commitment of New York State to design and build a new research laboratory, vivarium, nursing tower, ambulatory clinic and diagnostic and treatment facility, all in addition to major renovations to existing research facilities. The CCSG plays a central role in the planning and evaluation, support and administration of Roswell's basic and clinical research programs. With the renewal of this CCSG, combined with the commitment of New York State to support the cancer mission of Roswell Park and its highly dedicated research faculty, Roswell Park will be poised to enter the next century as one of the nations leading cancer centers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMPROVING ANIMAL RESOURCES FOR CANCER RESEARCH AT RPCI
Irinotecan in Combination with Celecoxib: A phase I Stu*
ROSWELL PARK DNA REPLICATION PROG FACIL: ANTITUMOR DRUG
ROSWELL PARK DNA REPLICATION PROG FACIL: GENET SMOKING